Literature DB >> 12641998

Glycoprotein D-adjuvant vaccine to prevent genital herpes.

Emily J. Erbelding.   

Abstract

Entities:  

Year:  2003        PMID： 12641998     DOI： 10.1007/s11908-003-0048-0

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN： 1523-3847            Impact factor:   3.725


× No keyword cloud information.
  3 in total

1.  Projection of the future dimensions and costs of the genital herpes simplex type 2 epidemic in the United States.

Authors:  David N Fisman; Marc Lipsitch; Edward W Hook; Sue J Goldie
Journal:  Sex Transm Dis       Date:  2002-10       Impact factor: 2.830

Review 2.  Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review.

Authors:  Jennifer S Smith; N Jamie Robinson
Journal:  J Infect Dis       Date:  2002-10-15       Impact factor: 5.226

3.  The estimated economic burden of genital herpes in the United States. An analysis using two costing approaches.

Authors:  T D Szucs; K Berger; D N Fisman; S Harbarth
Journal:  BMC Infect Dis       Date:  2001-06-28       Impact factor: 3.090
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.